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Abstract: Attention Deficit Hyperactivity Disorder (ADHD) is associated with poor self-control, under-
pinned by inferior fronto-striatal deficits. Real-time functional magnetic resonance neurofeedback
(rtfMRI-NF) allows participants to gain self-control over dysregulated brain regions. Despite evidence for
beneficial effects of electrophysiological-NF on ADHD symptoms, no study has applied the spatially
superior rtfMRI-NF neurotherapy to ADHD. A randomized controlled trial tested the efficacy of rtfMRI-
NF of right inferior prefrontal cortex (rIFG), a key region that is compromised in ADHD and upregu-
lated with psychostimulants, on improvement of ADHD symptoms, cognition, and inhibitory fMRI acti-
vation. To control for region-specificity, an active control group received rtfMRI-NF of the left
parahippocampal gyrus (lPHG). Thirty-one ADHD boys were randomly allocated and had to learn to
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INTRODUCTION
Attention Deficit Hyperactivity Disorder (ADHD) is a
male-predominant (4:1) childhood disorder of age-
inappropriate problems with inattention, impulsiveness,
and hyperactivity that persists into adulthood in most
cases and has a prevalence of around 7% [Thomas et al.,
2015]. Psychostimulants improve ADHD symptoms in
about 70% of patients with effect sizes of 0.6 for parent
and up to 0.8 for teacher ratings [Stevens et al., 2013].
Although superior to behavioral treatments in the short-
term, longer-term efficacy has not been demonstrated
[Cunill et al., 2016; Molina et al., 2009], which may be
related to evidence from positron emission tomography
studies for dopaminergic brain adaptation to psychostimu-
lant medication [Fusar-Poli et al., 2012; Wang et al., 2013].
Moreover, because of their potential for abuse and diver-
sion, adverse effects, and unknown longer-term brain
effects, non-pharmacological treatments are preferred, but
have limited efficacy [Sonuga-Barke et al., 2013].
Neurotherapies like neurofeedback (NF) that target the
key underlying neurobiological mechanisms are promising.
NF is an operant conditioning procedure that, by trial and
error, teaches participants to volitionally self-regulate spe-
cific regions/networks through real-time audio/visual feed-
back of their brain activation which can be represented on a
PC and gamified in an attractive way for children. Given
that ADHD is typified by poor self-control [Schachar et al.,
1993], and enhancing brain-self-control is the target of NF,
ADHD is the psychiatric disorder where NF has been most
applied, using electrophysiological neurofeedback (EEG-
NF) targeting abnormal EEG biomarkers. Meta-analyses of
randomized controlled trials (RCT) of EEG-NF show medi-
um effect sizes for symptom improvements [Arns et al.,
2009], reduced to trends when only “probably” blinded
raters are included [Holtmann et al., 2014; Sonuga-Barke
et al., 2013]. Crucially, unlike psychostimulant treatment,
NF effects seem stable and longer-lasting (up to 2 years),
with no side effects [Arns and Kenemans, 2014; Gani et al.,
2008; Gevensleben et al., 2010; Leins et al., 2007; Mayer
et al., 2016; Steiner et al., 2014; Strehl et al., 2006].
Brain regulation with EEG-NF requires typically dozens
of sessions [Thibault et al., 2016], in ADHD studies 30–40
hourly runs are commonly used [Arns et al., 2009]. Real-
time functional magnetic resonance imaging-NF (rtfMRI-
NF) teaches subjects to self-regulate blood-oxygen level-
dependent (BOLD) response in specific brain regions
based on real-time feedback of this response. The BOLD
self-regulation can be achieved in less than 40 min [Thi-
bault et al., 2016] in healthy adults. While more sessions
may be needed to achieve clinical efficacy in patient
groups like ADHD, the ability to learn to self-regulate
brain activation appears to be much faster with rtfMRI-NF
than EEG-NF [Thibault et al., 2016]. The faster learning
may be due to brain baroreceptors informing on blood
flow but not on electrical activity [Dworkin, 1988; Thibault
et al., 2016], and/or superior signal/contrast to noise ratio
and superior spatial localization specificity of the fMRI sig-
nal. Furthermore, EEG-NF cannot modulate activation in
key underfunctioning regions in ADHD found in fMRI
meta-analyses, such as right inferior frontal gyrus (rIFG)
or basal ganglia [Hart et al., 2013; Norman et al., 2016;
Rubia, 2011, 2017; Rubia et al., 1999, 2005, 2008, 2014a].
rIFG in particular is a key hub region mediating functions
that are compromised in ADHD like attention, inhibition,
and timing [Hugdahl et al., 2015; Kim, 2014; Radua et al.,
2014], and its activation correlates with behavioral impul-
siveness [Rubia et al., 1999, 2005]. rIFG underactivation in
ADHD is furthermore disorder-specific relative to other
childhood disorders such as conduct, obsessive-compulsive
and autism spectrum disorder [Chantiluke et al., 2015; Nor-
man et al., 2016; Rubia, 2011, 2017; Rubia et al., 2008, 2009b]
and is the region most consistently upregulated with single
and chronic stimulant medication doses [Norman et al.,
2016; Rubia et al., 2014b].
Healthy adults can upregulate rIFG in rtfMRI-NF within
4 runs of 8 minutes [Rota et al., 2009]. Studies in psychiat-
ric/neurological disorders highlight the clinical potential
of rtfMRI-NF [Thibault et al., 2015, 2016], showing general-
ization to NF-free transfer runs and longer-term beneficial
effects of up to several months [Zilverstand et al., 2015].
Importantly, by learning to self-upregulate isolated
regions, participants learn to co-regulate other areas inter-
connected with the target region, suggesting modulation
of entire networks [Emmert et al., 2016; Thibault et al.,
2016]. rtfMRI-NF of rIFG may hence be an attractive
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neurotherapy for ADHD children who typically have IFG-
striatal mediated self-regulatory problems [Cortese et al.,
2012; Hart et al., 2013; Norman et al., 2016; Rubia, 2011,
2017; Rubia et al., 1999, 2005, 2014a]. However, no study
has investigated rtfMRI-NF in ADHD children. Only one
recently published feasibility pilot study tested rtfMRI-NF
of dorsal anterior cingulate cortex (dACC) over 4 hourly
MRI sessions in combination with performance on a men-
tal calculation task expected to increase dACC activation
in seven adults with ADHD compared with six adults
with ADHD who performed the same training task in the
MRI scanner but did not receive rtfMRI-NF. The study
found that although both groups showed similar dACC
activation increases during training and transfer runs,
ADHD symptoms were not improved in either group.
Only the active, but not the control group, however,
showed performance improvements in sustained attention
and working memory, suggesting some superior effects of
rtfMRI-NF on cognitive performance. While the study was
underpowered to test potential clinical benefits, it showed
feasibility of rtfMRI-NF in ADHD adults [Zilverstand
et al., 2017].
We hence conducted the first proof-of-concept rtfMRI-
NF RCT in adolescents with ADHD to test whether
patients can learn to self-upregulate rIFG activation in 14
rtfMRI-NF runs. Given that rIFG underactivation is a con-
sistent, disorder-specific neurofunctional biomarker for
ADHD children and adults [Cortese et al., 2012; Hart
et al., 2013; Norman et al., 2016; Rubia, 2011, 2017; Rubia
et al., 1999, 2005, 2014a] and the main target of psychosti-
mulant medication [Norman et al., 2016; Rubia et al.,
2014b], we hypothesized that rtfMRI-NF of rIFG would
reduce ADHD symptoms and improve attention, inhibi-
tion, and timing functions mediated by this region as well
as enhance typically reduced rIFG activation [Cortese
et al., 2012; Hart et al., 2013; Norman et al., 2016; Rubia,
2011, 2017; Rubia et al., 1999, 2005, 2014a] during an fMRI
inhibition task, with no side effects and longer-term efficacy
6 months after treatment. To control for region-specificity
and learning, rather than a sham-NF control condition, we
used an active rtfMRI-NF control group, who was trained
to self-upregulate another region not impaired in ADHD.
MATERIALS AND METHODS
Participants
Thirty-one right-handed [Oldfield, 1971], 12–17 year-old
boys, with a clinical DSM-5 ADHD diagnosis, combined
hyperactive/impulsive and inattentive (N 5 27) or inatten-
tive subtypes (N 5 4), as assessed by an experienced child
psychiatrist and confirmed with the Schedule of Affective
Disorders and Schizophrenia for School-Age Children-Pre-
sent and Lifetime version (K-SADS-PL) [Kaufman et al.,
1996], were recruited from South London clinics. They also
scored above clinical ADHD threshold on the Conners’
Parent Rating Scale (CPRS-R), a parent rated index of
ADHD severity [Conners et al., 1998]. The Social Commu-
nication Questionnaire (SCQ) [Rutter et al., 2003] screened
for autism spectrum disorders. Six boys met/exceeded the
cut-off score of 15 (2 active, 4 controls), but a possible
autism spectrum condition was ruled out by clinical inter-
view. General functioning and symptom severity were
assessed with the Children’s Global Assessment Scale
(CGAS) [Shaffer et al., 1983].
Exclusion criteria were IQ< 80 [Wechsler, 2011], alcohol
or substance abuse, neurological or comorbid psychiatric
disorders, except for disruptive behavior disorder, and
MRI contraindications. Twenty-four boys received stable
psychostimulant administration throughout the rtfMRI-NF
period. Baseline testing started at least 7 days after titration
(methylphenidate: NActive5 13, NControl5 9, dexamphetamine:
NActive5 2). One control boy was medication-na€ıve, and 3
boys of the active and 3 boys of the control group ceased
taking medication for at least 7 days before baseline testing.
The study was approved by the local ethics committee and
conducted in accordance with the Declaration of Helsinki.
Written informed assent/consent was obtained from each
participant/legal guardian. Participants received £20 for each
of the 1–1.5 hr rtfMRI-NF scan visit, and up to £10 for best
performance during the session, as well as £30 for the post-
training neuropsychological assessment, in total up to £150.
They were also reimbursed for travel expenses.
Experimental Design
A single-blind RCT (ISRCTN: 12800253) with an active
control group compared the effects of rtfMRI-NF of the
rIFG (active group) and of the left middle parahippocam-
pal gyrus (lPHG; control group), thought to mediate
visual-spatial processing and episodic memory, and be
crucial for spatio-temporal context association [Aminoff
et al., 2013]. A random permuted block design was used
for randomization of participants in a 4-to-3 ratio with
randomly varying block size [Matts and Lachin, 1988].
Children and parents were blinded to group allocation; for
practical reasons, this was not possible for researchers.
rtfMRI Protocol
Boys were offered 14 rtfMRI-NF runs (8.5min each) in
four 1–1.5 hr scan visits over 2 weeks. Each rtfMRI-NF run
consisted of seven rest (30 s) and six activation (50 s)
blocks, starting with a rest block showing an underwater
dolphin image, while activation blocks showed a video-
clip of a rocket (Fig. 1). Boys were asked to move the rock-
et toward space by any means they found helpful. Instruc-
tions were minimal (i.e., “you can try to concentrate on
the rocket” or “try any other method that works for you”)
as this has been shown to be more effective than explicit
instructions [Sulzer et al., 2013], and instruction-free
approaches are common in EEG-NF for ADHD children
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[Gevensleben et al., 2014; Strehl et al., 2006]. However, in
rtfMRI-NF it has been shown that for some regions it
appears to make no difference whether instructions are
given (e.g., motor regions [Sepulveda et al., 2016]), while
explicit instructions may be beneficial for the self-regulation
of specific brain areas (e.g., limbic system [Zilverstand
et al., 2015]. They received continuous feedback (every repe-
tition time (TR), i.e., 2 s), about their brain activation in
their target region of interest (ROI) via the rocket video-
clip, with the direction and distance travelled in space pro-
portional to their BOLD response. To enhance motivation, a
score (0–10), reflecting the percentage of distance travelled
through space during each run, appeared on the screen
(e.g., 6 for 60%) and a monetary incentive (e.g., £6 for 6/
60%) corresponding to the best performance in the session
was given after the scan. Between runs (a few minutes’
break), researchers briefly acknowledged the effort in not
moving the head, reminded participants to keep doing so,
and congratulated the participants for the score they
obtained.
Between visits, boys had to practice daily brain self-
regulation using a cue card depicting the video-clip rocket.
After the last rtfMRI-NF run, a 5-minute fMRI transfer run
was conducted, which was identical to the NF training
runs, using the same stimuli, but without the feedback
(the rocket did not move), consisting of four rest and three
activation blocks. Transfer runs measure retention of learn-
ing and are considered a proximal measure of successful
transfer of training strategies to everyday life [Drechsler
et al., 2007].
Figure 1.
Schematic overview of the design of the rtfMRI-NF study.
ADHD-RS, Attention Deficit Hyperactivity Disorder-Rating
Scale; CGAS, Children’s Global Assessment Scale; CIS, Columbia
Impairment Scale; CPRS-R, Conners’ Parent Rating Scale-
Revised; K-SADS-PL, Kiddie-SADS-Present and Lifetime Version;
MARS, Maudsley Attention and Response Suppression task
battery; NF, Neurofeedback; SCQ, Social Communication Ques-
tionnaire (Lifetime); Wechsler Abbreviated Scale of Intelligence,
2nd Edition (WASI-II); WREMB-R, Weekly Rating of Evening and
Morning Behavior-Revised. [Color figure can be viewed at
wileyonlinelibrary.com]
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Outcome Measures
Clinical measures
The primary outcome measure was the ADHD Rating
Scale (ADHD-RS-IV), a standard tool to assess ADHD symp-
toms according to DSM-IV-TR and to monitor treatment
effects [Dupaul et al., 1998], the secondary outcome measure
was the CPRS-R ADHD index [Conners et al., 1998], both
rated by parents. ADHD-related difficulties and functional
impairments were assessed with the Weekly Parent Ratings
of Evening and Morning Behavior-Revised scale (WREMB-
R) [Wehmeier et al., 2009] and the Columbia Impairment
Scale-Parent version (CIS) [Bird et al., 1993], respectively.
Neurocognitive measures
Performance on tasks of inhibition, sustained attention,
time estimation and temporal discounting were measured
using the Maudsley Attention and Response Suppression
task battery (MARS) [Rubia et al., 2007a] (see Supporting
Information), including a Go/No-Go Task (main depen-
dent variable: probability of inhibition), a Continuous Per-
formance Task (CPT; omission and commission errors), a
Time Discrimination Task (TD; errors), and an individually
adjusted Delay Discounting Task (DD) (impulsiveness fac-
tor k) [Kekic et al., 2014; Rubia et al., 2009a].
fMRI stop task
An fMRI version of an individually adjusted visual
tracking Stop task [Chantiluke et al., 2015; Rubia et al.,
2003, 2005, 2007b, 2011, 2014b], measuring motor response
inhibition, was administered immediately before and after
the rtfMRI-NF training. The contrast of successful Stop-Go
trials assessed inhibitory activation. The dependent behav-
ioral variable is the Stop Signal Reaction Time (SSRT)
which is calculated by subtracting the mean delay time
from the mean reaction time to go trials [Logan et al.,
1997] (see Supporting Information for details of the task
and fMRI acquisition protocol).
Safety and feasibility measures
Parents completed safety [Hill and Taylor, 2001] and
adverse effects scales (adapted from [D€opfner et al., 2006]
and rated their child’s frequency of self-regulation practice
and ability to apply the learned strategies in daily life
using a scale from 0 (not at all/never) to 4 (definitely/
always) [Maurizio et al., 2014]. Boys rated their learning,
self-regulation practice, transfer to daily life, mood, moti-
vation, and overall impression of the rtfMRI-NF training
[Maurizio et al., 2014].
The ADHD-RS, CPRS-R, WREMB-R, CIS, MARS Task
battery, and side effects were completed approximately 1
month before the rtfMRI-NF (pre) and 1 week after the
last rtfMRI-NF run (post). Parents and children rated the
rtfMRI-NF training experience and treatment allocation
guess after post-assessment. Follow-up (FU) measures
were obtained for ADHD-RS a minimum of 6 months after
the last rtfMRI-NF run (Fig. 1).
rtfMRI-NF Data Acquisition and Processing
Functional and structural images were acquired on a 3T
General Electric MR750 scanner with a 12-channel head
coil at the Centre for Neuroimaging Sciences, King’s College
London. A T1-weighted structural scan, used as structural
localizer, was acquired before the fMRI runs (see Supporting
Information for further details).
A custom rtfMRI-NF interface system [Bodurka and Ban-
dettini, 2008] and the AFNI software [Cox, 1996] were used
for real-time transfer and analysis of the fMRI data. The
rtfMRI-NF interface system ran on the scanner hardware to
access the fMRI scans as they were reconstructed. The images
were then transferred to an external Linux workstation where
they were pre-processed using AFNI, a software with built-in
real-time capacities. The effects of head motion were cor-
rected in real-time by the AFNI software, displaying graphs
of the motion parameters in real-time on the screen. We used
the CA_N27_ML/TT_N template to define the target ROIs
(ROITAR) in AFNI structurally for each adolescent before each
rtfMRI-NF session. The ROITAR for the active group was the
rIFG comprising of the pars triangularis (14,138 voxels in the
Talairach space of the template and 385 voxels when mapped
to fMRI space) and the pars orbitalis (11,484 voxels in the
Talairach space of the template and 308 voxels when mapped
to fMRI space). For the control group the ROITAR was the
lPHG (5,976 voxels in the Talairach space of the template and
149 voxels when mapped to fMRI space). A customized
AFNI script automatically created a native-space image mask
of the ROITAR and the white matter (used as reference region,
ROIREF, to cancel out non-specific global brain effects) based
on the T1-weighted structural image and a two-volume EPI
localizer image matched to the fMRI sequence for the geo-
metric distortion inherent in EPI acquisitions.
The image mask of the pre-selected ROIs was applied to
the pre-processed fMRI images to extract in real-time the
mean BOLD signal from each ROI. For each newly
acquired brain volume, AFNI calculated a new set of values
for each ROI, which were fed to a locally written program
that generated a dynamic visual feedback display by means
of the moving rocket. The threshold required for the rocket
to move up was continuously updated based on past perfor-
mance ((ROITAR2ROIREF)2 (ROITARPrevious2ROIREFPre-
vious)), where ROIREFPrevious and ROITARPrevious are the
average activation of ROIREF and ROITAR in the previous
rest block. Boys were informed of the NF delay (6 s),
caused by hemodynamic delay and data processing time.
Data Analysis
Behavioral data
Some participants did not complete all cognitive tasks
due to time constraints, while some parents did not fill in
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all questionnaires. Missing data (<5%) were assumed to
be completely at random; missing pre-treatment values
were replaced by group means [White and Thompson,
2005]. Multiple (i.e., 20) imputations were used for missing
post-treatment data. The individual estimates from the
multiply imputed datasets were then used to calculate a
combined estimate by applying Rubin’s Rules [Little and
Rubin, 2002]. Repeated-measures mixed ANOVAs tested
within- and between-group effects. Effect size (Cohen’s d)
was calculated as the difference between the means (pre-
post, pre-FU) divided by the corresponding pooled stan-
dard deviation. One-tailed Pearson correlation analyses
tested correlations between rtfMRI-NF induced brain acti-
vation changes and primary and secondary clinical out-
come changes.
rtfMRI-NF Data
All 31 participants (NActive5 18; NControl5 13) were
included in the rtfMRI-NF data analyses. Mostly due to
technical difficulties and consequent time constraints, only
11 participants completed all 14 rtfMRI-NF runs
(NActive5 5; NControl5 6). Due to the relative novelty of
installing rtfMRI-NF on one of our new 3T scanners, sever-
al technical problems occurred such as the scanner did not
reconstruct images, issues with creating the mask, or com-
munication problems between the various components of
the NF pipeline, for example, no data transfer from the
scanner to the processing server, or ROI information was
not transferred to the paradigm presentation software,
resulting in lack of feedback for the participants, all of
which caused loss of rtfMRI-NF runs. The average number
of rtfMRI-NF runs was 11 (see Table Id). Therefore, only
runs completed by at least 65% of the participants were
included, resulting in only the first 11 (or earlier) rtfMRI-
NF runs being analyzed (Table Id).
The non-parametric XBAM software (www.brainmap.co.
uk) [Brammer et al., 1997] was used for post-scanning anal-
yses of the rtfMRI-NF data as non-parametric analyses
overcome many of the issues of parametric analytical meth-
ods leading to high false positive rates [Eklund et al., 2016].
rtfMRI-NF brain activation was first analyzed for
each subject for each of the up to 11 rtfMRI-NF runs
The individual and group-level analysis methods are
described in detail elsewhere [Brammer et al., 1997; Bull-
more et al., 1999a; Bullmore et al., 1999b] and in the Sup-
porting Information.
Briefly, fMRI data were realigned to minimize motion-
related artifacts and smoothed using a 7.8 mm full-width-at-
half-maximum (FWHM) Gaussian filter. Time-series analy-
sis of individual activation was performed with a wavelet-
based resampling method [Bullmore et al., 2001]. The main
experimental conditions [NF–baseline; i.e., the response size
to the NF (active block) condition against the baseline (rest
block) condition] were convolved with 2 Poisson model
functions (peaking at 4 and 8 s). The weighted sum of these
convolutions giving the best fit (least-squares) to the time
series at each voxel was calculated. A goodness-of-fit statis-
tic (SSQ ratio) was then computed at each voxel consisting
of the ratio of the sum of squares of deviations from the
mean intensity value due to the model (fitted time series)
divided by that of the squares due to the residuals (original
minus model time series). This statistic, the SSQ ratio, was
used in further analyses. Individual maps were then nor-
malized to Talairach space [Talairach and Toumoux, 1988],
and a group activation map was produced for each group (see
Supporting Information for details).
Repeated-measures ANOVA comparing groups in
activation changes to the last minus the first rtfMRI-
NF run in the two ROIs
Next, repeated-measures ANOVAs tested group differ-
ences in activation in the trained ROIs of rIFG and lPHG
between the last (11th or earlier) and first rtfMRI-NF run.
For this purpose, a repeated-measures ANOVA, with first
and last (11th or earlier) rtfMRI-NF run as repeated-
measures and group as independent measure, was applied
to compare groups in their activation changes between the
first and last rtfMRI-NF run in the two ROIs. This allowed
us to examine whether the active group would show
increased activation in the last relative to the first rtfMRI-
NF run compared with the control group in their ROI-
rIFG, while the control group would show increased acti-
vation in the last versus first rtfMRI-NF run compared
with the active group in their ROI-lPHG. For this purpose,
randomization-based tests for voxel- or cluster-wise differ-
ences were again used as described above, and in detail
elsewhere [Bullmore et al., 1999b, 2001]. For this analysis,
less than one false positive cluster per map was obtained
with voxel-level P < 0.05 and cluster-level P < 0.01.
Group differences in linear correlation between brain
activation in ROIs and number of rtfMRI-NF runs
To test our hypothesis that each group would show a
linear progressive activation increase in the trained ROI
compared with the other group with increasing number of
rtfMRI-NF runs, we conducted a group comparison of the
linear correlation between activation in the ROI and num-
ber of rtfMRI-NF runs. To conduct this analysis, a summa-
ry statistical map for each rtfMRI-NF run for each group
was constructed by averaging the statistical maps of all
participants who had data for that rtfMRI-NF run, result-
ing in one set of 11 average maps per group.
(a) To test for a linear correlation between ROI activa-
tion and number of rtfMRI-NF runs for each group, the
Pearson product-moment correlation coefficient was first
computed at each voxel in standard space between the
number of rtfMRI-NF runs and signal change within each
group. Correlation coefficients were recalculated after
r Alegria et al. r
r 6 r
randomly permuting the run numbers, but not the fMRI
data. Multiply repeating the second step (50 times per
voxel, then combining over all voxels) gives the distribu-
tion of correlation coefficients under the null hypothesis of
no association between number of rtfMRI-NF runs and
specific BOLD ROI effects. This null distribution can then
be used to assess the probability of any particular correla-
tion coefficient under the null hypothesis. For this analysis,
the thresholds were set at P < 0.05 for voxel-level and P <
0.05 for cluster-level to give less than one false positive
cluster per map.
(b) To test whether groups had differential effects on lin-
ear correlations between the number of rtfMRI-NF runs
and brain activation in the two trained ROIs, group differ-
ences were examined in the correlation coefficients of brain
activation in the respective ROIs and number of rtfMRI-NF
runs. For each group independently, the average Pearson
product-moment correlation coefficient between number of
rtfMRI-NF runs and BOLD response in the two ROIs was
computed (see above) and group differences in correlation
calculated. To determine the significance of this difference,
the appropriate null distribution was generated by
TABLE I. Demographic, clinical, and medication status characteristics and number of rtfMRI-NF runs in active and
control group
Both groups
combined (N 5 31)
Active group
(N 5 18)
Control group
(N 5 13)
Between-subject
ANOVA
Mean (SD)
or n (%)
Mean (SD)
or n (%)
Mean (SD)
or n (%) F(1,29)/v2 P
(a) Demographics
Age in years 13.90 (1.58) 14.11 (1.53) 13.62 (1.66) 0.74 0.40
IQ (WASI-II) 103.45 (14.28) 103.83 (15.95) 102.92 (12.20) 0.03 0.86
Years of education 9.32 (1.51) 9.50 (1.58) 9.08 (1.44) 0.58 0.45
Age at onset of ADHD (years) 6.68 (1.82) 6.72 (2.19) 6.62 (1.19) 0.03 0.88
Social communication questionnaire 9.24 (5.91) 8.97 (5.68) 9.62 (6.44) 0.09 0.77
Children’s global assessment scale 49.77 (8.33) 51.17 (7.68) 47.85 (9.09) 1.21 0.28
Oppositional defiant disorder comorbidity 14 (45.20%) 7 (38.90%) 7 (53.80%) 0.68 0.41
(b) Clinical measures
ADHD-Rating Scalea
ADHD-RS total score 37.16 (10.13) 36.72 (9.43) 37.77 (11.39) 0.08 0.78
ADHD-RS inattention 20.29 (4.47) 19.83 (4.46) 20.92 (4.59) 0.44 0.51
ADHD-RS hyperactivity/impulsivity 16.87 (6.39) 16.89 (5.71) 16.85 (7.48) 0.00 0.99
Conner’s Parent Rating Scale (T-score)
ADHD indexb 14.81 (4.29) 13.61 (4.80) 16.46 (2.88) 3.62 0.07
Global index 85.42 (6.62) 84.06 (6.81) 87.31 (6.10) 1.74 0.20
Inattention 83.06 (6.74) 81.72 (7.20) 84.92 (5.81) 0.06 0.80
Hyperactivity/impulsivity 85.42 (9.29) 85.06 (9.56) 85.92 (9.28) 1.87 0.18
DSM-5 attention 81.16 (8.53) 79.06 (8.98) 84.08 (7.19) 2.77 0.11
DSM-5 hyperactivity/impulsivity 85.48 (9.13) 85.56 (9.22) 85.38 (9.39) 0.00 0.96
Kiddie-SADS-Present and Lifetime Version (ADHD module)
Total number of ADHD symptoms 14.19 (2.59) 14.28 (2.30) 14.08 (3.04) 0.04 0.84
Inattention symptoms 7.74 (1.15) 7.72 (1.18) 7.77 (1.17) 0.01 0.91
Hyperactivity/impulsivity symptoms 6.48 (1.93) 6.56 (1.54) 6.31 (2.46) 0.12 0.73
WREMB-R Total score 21.67 (6.45) 21.17 (6.78) 22.36 (6.16) 0.25 0.62
Columbia impairment scale 23.87 (11.70) 20.94 (10.93) 27.91 (11.94) 2.84 0.10
Side effects 16.87 (7.58) 15.11 (6.74) 19.30 (8.25) 2.41 0.13
(c) Medication status 1.74 0.42
Medication na€ıve 1 (3.2%) 0 (0%) 1 (7.70%)
On stimulant medication 24 (77.40%) 15 (83.30%) 9 (69.20%)
Off stimulant medication 6 (19.40%) 3 (16.70%) 3 (23.10%)
(d) real-time fMRI Neurofeedback (rtfMRI-NF) runs
Number of rtfMRI-NF runs (max 14) 11.65 (2.50) 11.11 (2.81) 12.38 (1.85) 2.03 0.17
Completed 111 rtfMRI-NF runs 21 (67.70%) 11 (61.10%) 10 (76.90%) 0.86 0.35
Completed all 14 rtfMRI-NF runs 10 (32.26%) 4 (22.22%) 6 (46.20%) 1.98 0.16
WREMB-R, Weekly Rating of Evening and Morning Behavior-Revised; WASI, Wechsler Abbreviated Score of Intelligence, second
edition.
aPrimary outcome measure.
bSecondary outcome measure.
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randomly permuting subjects and rtfMRI-NF run numbers
between groups, thus scrambling any group differences.
For each permutation, the correlation difference between
scrambled groups was calculated and resulting values were
combined over all voxels to produce a whole-brain null dis-
tribution of differences in correlation. Testing was then
extended to cluster-level, with thresholds being set at P <
0.05 for voxel-level and P < 0.05 for cluster-level to give
less than one false positive cluster per map.
We used each trained ROI as mask and reported areas
within the rIFG and lPHG ROIs in which either group
showed significantly increased correlation between activa-
tion in ROIs and number of rtfMRI-NF runs compared
with the other group. We then determined the direction of
group differences in correlations between BOLD response
in ROIs and number of rtfMRI-NF runs by conducting
post-hoc analyses on the statistical measures of the BOLD
response extracted for each group in these regions and
correlations with number of rtfMRI-NF runs for all clusters
within each group.
Whole-brain correlation analyses
To examine (a) common and (b) differential self-
regulation effects across the whole brain, (a) a whole-brain
correlation analysis tested for regions that showed a linear
increase/decrease in activation with number of rtfMRI-NF
runs across both groups and (b), a group comparison test-
ed regions that were differentially linearly increased/
decreased in activation with number of rtfMRI-NF runs.
(a) Linear correlation between whole-brain activation and
number of rtfMRI-NF runs across both groups. An aver-
age statistical map for each rtfMRI-NF run for the combined
group was constructed by averaging the statistical maps of
all participants that have data for that rtfMRI-NF run,
resulting in one set of 11 average maps across both groups.
To test for a linear correlation between whole-brain activa-
tion and number of rtfMRI-NF runs, the Pearson product-
moment correlation coefficient was first computed at each
voxel in standard space between the number of rtfMRI-NF
runs and signal change. The data were further analyzed
identical to that described in section “Group Differences in
Linear Correlation Between Brain Activation in ROIs and
Number of rtfMRI-NF Runs”) with the exception that no
ROI mask was applied. For this analysis, the statistical
thresholds were set at P < 0.05 for voxel-level and P <
0.003 for cluster-level to give less than one false positive
cluster per map.
(b) Group differences in correlation between whole-brain
activation and number of rtfMRI-NF runs. To test for
group differences between linear correlations between
brain activation and number of rtfMRI-NF runs across the
whole brain, the same analysis was conducted as in the
ROI group difference analysis described in “ Group Differ-
ences in Linear Correlation Between Brain Activation in
ROIs and Number of rtfMRI-NF Runs,” with the exception
that no ROI mask was applied. The statistical thresholds
were set at P < 0.05 for voxel-level and P < 0.003 for
cluster-level to give less than one false positive cluster per
map.
fMRI Transfer Session
Individual data were analyzed as in section “rtfMRI-NF
Brain Activation was First Analyzed for Each Subject for
Each of the Up To 11 rtfMRI-NF Runs.” Next, two mixed
ANOVAs were conducted to compare groups in their acti-
vation changes between the transfer (no feedback) and
baseline (rest) condition in the two ROIs (rIFG, lPHG). The
statistical thresholds were set at P < 0.05 for voxel-level
and P < 0.05 for cluster-level to give less than one false
positive cluster per map.
fMRI Stop Task
The individual and group analysis was identical to the
rtfMRI-NF runs processing described in detail in section
“rtfMRI-NF Brain Activation was First Analyzed for Each
Subject for Each of the Up To 11 rtfMRI-NF Runs”), except
for the experimental condition comparisons. Specifically, at
individual subject-level, the estimates of the response size
to the stop task condition against an implicit baseline (suc-
cessful stop-go trials) condition were obtained by using
the standard GLM approach.
For between-group comparisons between active and
control group under either pre- and post-rtfMRI-NF train-
ing, a repeated-measures ANOVA was conducted to test
the interaction effect of time (pre, post) by group (active,
control). For this analysis, thresholds were set at P < 0.05
for voxel-level and P < 0.01 for cluster-level to give less
than one false positive cluster per map. Given that the
main hypothesis was that the rIFG would show increased
activation in the active compared with the control group
post- relative to pre-rtfMRI-NF training, a more lenient
exploratory cluster-level threshold of P < 0.03 was also
applied to test for rIFG activation changes for the group
by time interaction.
RESULTS
There was no group imbalance in demographic, clinical
or medication status measures (Table Ia-c). Active and
control groups did not differ in type of ADHD-prescribed
medication (v1
25 1.31, P 5 0.3). Children’s (v2
25 2.15, P 5
0.34) and parents’ guess of treatment allocation was not
above chance (v2
25 3.35, P 5 0.19). No group differences
were observed in mood, motivation, or overall (positive)
impression of the rtfMRI-NF training (Supporting Informa-
tion Table 1). Groups did not differ in their rtfMRI-NF
performance score gain between last (11th or earlier) and
first rtfMRI-NF run (MeanActive5 2.22 [SD5 27.34];
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MeanControl5 10.00 [SD5 25.17]; t29520.81, P5 0.43).
Children’s and parents’ ratings of transfer, learning, and
practice effects did not differ between groups (t< 0.35,
P> 0.28).
Participants were debriefed about the strategies used
during training runs at the end of every NF session.
Although five participants (all from the active group)
could not describe any conscious strategies, those who
did, reported up to seven different strategies used
throughout their training sessions. Strategies most frequently
reported were “Focusing” (e.g., looking at the screen, con-
centrating, and focusing on the rocket or a particular part of
it) (NActive5 8; NControl5 7), “Music” (e.g., thinking about
lyrics/music, singing internally) (NActive5 9; NControl5 6),
“Instructing” (e.g., imagining the rocket going up or saying
“go up,” “fly,” or “higher”) (NActive5 6; NControl5 4),
“Relaxing” (including focusing on breathing, and thinking of
nothing) (NActive5 3; NControl5 7), and “Number Processing”
(e.g., counting and doing simple maths) (NActive5 4;
NControl5 4). None of the participants were able to identify a
strategy that worked consistently for them to achieve upre-
gulation of their target ROI.
Pre-Post Comparisons of Outcome Measures
Within-group comparisons showed that ADHD symp-
toms decreased significantly in both groups from pre- to
post-treatment, for all primary and secondary outcome
measures, with only a trend-wise significant reduction in
ADHD-RS hyperactivity/impulsivity subscale in the active
group (Table II). Between-group comparisons showed a
TABLE II. Behavior ratings before and after real-time fMRI neurofeedback training for each group
Pre Post Pre FU
Pre-Post Pre-FU
Mean (SD) Mean (SD) Mean (SD) Mean (SD) F P ES d F P ES d
(a) Active group N 5 18 N 5 13a F(1,17) F(1,12)
ADHD-Rating Scale
ADHD-RS total score 36.72 (9.43) 30.15 (11.63) 36.38 (9.85) 26.77 (10.58) 6.00 0.025b 0.62 6.25 0.028 0.94
ADHD-RS inattention 19.83 (4.46) 15.94 (6.78) 19.54 (4.37) 15.31 (5.31) 6.38 0.022 0.68 4.26 0.061 0.87
ADHD-RS hyperactivity/impulsivity 16.89 (5.71) 14.21 (6.15) 16.85 (5.90) 11.46 (5.67) 3.82 0.067b 0.45 7.63 0.017 0.93
Conner’s Parent Rating Scale (T-score)
ADHD index 13.61 (4.80) 10.67 (5.79) 5.29 0.034c 0.55
Global index 84.06 (6.81) 76.42 (12.16) 8.91 0.008 0.78
Inattention 81.72 (7.20) 74.30 (9.19) 8.45 0.010 0.90
Hyperactivity/impulsivity 85.06 (9.56) 78.83 (14.42) 9.15 0.008 0.51
DSM-5 attention 79.06 (8.98) 72.20 (8.19) 4.97 0.040 0.80
DSM-5 hyperactivity/impulsivity 85.56 (9.22) 80.51 (13.66) 7.07 0.017 0.43
WREMB-R Total score 21.17 (6.78) 20.71 (7.39) 0.16 0.699 0.06
Columbia impairment scale 20.94 (10.93) 20.12 (7.86) 0.18 0.677 0.09
Side effects 15.11 (6.74) 15.17 (7.39) 0.00 0.974 0.01
(b) Control group N 5 13 N 5 10d
ADHD-Rating Scale F(1,12) F(1,9)
ADHD-RS total score 37.77 (11.39) 29.30 (10.95) 36.80 (8.93) 31.00 (12.45) 49.42 <0.001 0.76 5.02 0.052 0.54
ADHD-RS inattention 20.92 (4.59) 16.04 (6.28) 20.10 (4.18) 17.00 (6.86) 30.47 <0.001 0.89 6.93 0.027 0.45
ADHD-RS hyperactivity/impulsivity 16.85 (7.48) 13.26 (6.14) 16.70 (5.44) 14.00 (7.09) 16.35 0.002 0.52 2.58 0.143 0.43
Conner’s Parent Rating Scale (T-score)
ADHD index 16.46 (2.88) 11.90 (5.20) 18.63 0.001 1.08
Global index 87.31 (6.10) 80.64 (13.12) 6.30 0.027 0.65
Inattention 84.92 (5.81) 76.61 (10.89) 7.18 0.020 0.95
Hyperactivity/impulsivity 85.92 (9.28) 81.05 (13.04) 3.61 0.082 0.43
DSM-5 attention 84.08 (7.19) 71.68 (13.06) 11.82 0.005 1.18
DSM-5 hyperactivity/impulsivity 85.38 (9.39) 82.21 (12.46) 2.68 0.128 0.29
WREMB-R Total score 22.36 (6.16) 17.17 (6.91) 12.38 0.004 0.79
Columbia impairment scale 27.91 (11.94) 23.52 (10.22) 5.02 0.045 0.40
Side effects 19.30 (8.25) 15.72 (8.09) 11.25 0.006 0.44
Primary outcome measure is printed in bold and the secondary outcome measure is printed in bold italic. FU, follow-up; ES d, effect
size (Cohen’s d); WREMB-R, Weekly Rating of Evening and Morning Behavior-Revised.
aFollow-up rating scores for the ADHD-RS could not be obtained for five boys of the active group.
bTrend-level correlation with brain activity in the last versus the first rtfMRI-NF run in rIFG ROI and ADHD-RS total score (P 5 0.09)
and ADHD-RS hyperactivity/impulsivity score (P 5 0.07).
cSignificant correlation with brain activity in rIFG ROI during transfer relative to baseline (rest) condition (P 5 0.02).
dFollow-up rating scores for the ADHD-RS could not be obtained for three boys of the control group.
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significant effect of time in primary (ADHD-RS total scale,
F1,295 20.41, P < 0.001, d 5 0.69; ADHD-RS Inattention
subscale, F1,295 19.85, P < 0.001, d 5 0.79; ADHD-RS Hyper-
activity/Impulsivity subscale, F1,295 12.33, P < 0.001, d 5
0.49) and secondary outcome measures (CPRS-R ADHD-
Index, F1,295 18.25, P < 0.001, d 5 0.73), with medium effect
sizes, but no group or group by time interaction effects (time
by group interaction analyses: ADHD-RS total score,
F1,295 0.33, P 5 0.6; ADHD-RS inattention, F1,295 0.25, P 5
0.6; ADHD-RS hyperactivity/impulsivity, F1,295 0.26, P 5
0.6; Conner’s Parent Rating Scale ADHD index, F1,295 0.85,
P 5 0.4).
No significant performance effects were observed within
groups except for trend-level reduced CPT commission
errors in the active group post- relative to pre-rtfMRI-NF
(Table III). No group by time interaction effects were sig-
nificant (F1,29<1.99, P> 0.17).
No significant correlations were observed between the
number of rtfMRI-NF runs and the ADHD-RS total score
or the CPRS-R ADHD index score.
Pre-FU Comparison of ADHD-RS Scores
Eight parents did not provide ADHD-RS measures at
FU (NActive5 5, NControl5 3) and others only provided
them some time after the 6 months request (time range:
6–20 months). Groups did not differ in the average time
(in months) of FU assessment (MeanActive5 12.15
[SD5 5.38]; MeanControl5 9.90 [SD5 4.95], t215 1.03, P 5
0.3), with an average FU of 11 months (Mean 5 11.17
[SD5 5.21]. No participant changed type or medication
dose or started any other treatment during the rtfMRI-NF
period. However, during the FU period, medication sta-
tus/dose changed in seven participants, but no group dif-
ferences were observed in medication status (v2
25 1.38, P
5 0.5) or dose (v4
25 2.93 P 5 0.6) (active group: one child
discontinued stimulant medication treatment, one child
changed type of stimulant medication, and one child
increased dose of medication; control group: two children
lowered and two children increased their dose of medica-
tion). Medication status was not reported for one boy in
the active group.
At FU relative to pre-rtfMRI-NF, ADHD-RS total scores
(F1,125 6.25, P 5 0.03, d 5 0.94) and ADHD-RS hyperac-
tive/impulsive scores (F1,125 7.63, P 5 0.02, d 5 0.93) sig-
nificantly decreased in the active group with large effect
sizes and ADHD-RS inattentive scores in the control group
with small effect size (F1,95 6.93, P 5 0.03, d 5 0.45; Table
II). Between-group comparisons showed a significant effect
of time in all ADHD-RS scores (ADHD-RS total score,
F1,215 9.69, P 5 0.005, d 5 0.77; ADHD-RS Inattention
TABLE III. Summary of performance measures at pre-test and post-test for each group
Pre-test Post-test
Within-subject ANOVA
Mean (SD) Mean (SD) F(df) P ES d
(a) Active group (N 5 18) F(1,17)
Go/No-go Task
Probability of inhibition (%) 61.28 (3.45) 64.87 (3.99) 0.08 0.38 20.96
Time Discrimination Task
Errors (%) 22.06 (4.49) 23.39 (4.44) 0.51 0.49 20.30
Temporal Discounting Task
k median 0.01 (0.00) 0.02 (0.00) 2.35 0.14 0
Continuous Performance Task
Omission errors (%) 8.17 (1.86) 7.89 (1.61) 0.04 0.85 0.16
Commission errors (%) 1.44 (0.41) 0.72 (0.20) 3.84 0.07 2.23
Stop task
Stop signal reaction time (ms) 110.17 (42.24) 108.27 (49.05) 0.00 0.96 0.04
(b) Control group (N 5 13) F(1,12)
Go/No-go Task
Probability of inhibition (%) 64.15 (6.77) 62.52 (6.76) 0.14 0.72 0.24
Time Discrimination Task
Errors (%) 24.00 (3.66) 25.83 (3.60) 0.57 0.47 20.50
Temporal Discounting Task
k median 0.02 (0.01) 0.02 (0.00) 0.10 0.76 0
Continuous Performance Task
Omission errors (%) 8.46 (1.58) 7.14 (1.18) 0.48 0.50 0.94
Commission errors (%) 0.69 (0.18) 0.68 (0.32) 0.00 0.95 0.04
Stop task
Stop signal reaction time (ms) 88.77 (42.67) 155.08 (55.21) 2.15 0.17 21.34
ES d, effect size (Cohen’s d).
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score, F1,215 8.17, P 5 0.009, d 5 0.74; ADHD-RS Hyperactiv-
ity/impulsivity score, F1,215 9.16, P 5 0.006, d 5 0.71), but
no group or group by time interaction effects (Time by group
interaction analyses: ADHD-RS total score, F1,215 0.59, P 5
0.5; ADHD-RS inattention, F1,215 0.19, P 5 0.7; ADHD-RS
hyperactivity/impulsivity, F1,215 1.01, P 5 0.3).
Figure 2.
Regional Brain Activation Changes in the Active Relative to
the Control Group (left panel) and the Control Relative to
the Active Group (right panel) in the two ROIs. (A) ANOVA
results showing one region (in BA 45) within the right inferior
frontal gyrus (rIFG) ROI that was significantly more activated
in the last relative to the first rtfMRI-NF run in the active
compared with the control group; no significantly increased
activation was observed in the control compared with the
active group within their ROI (left parahippocampal gyrus,
lPHG). The same region in BA 45 was also significantly more
activated in the transfer relative to baseline (rest) condition in
the active relative to the control group (A, D). (B–G) Shown
are brain regions within each ROI that show significantly pro-
gressively increased activations with increasing number of
rtfMRI-NF runs for the active compared with the control
group and for the control compared with the active group
(E–G). (B) Two regions within rIFG ROI (in BA 45 and BA 44)
were significantly more linearly activated across the 11
rtfMRI-NF runs in the active relative to the control group. (C)
For each cluster within the rIFG ROI that showed a significant
increase in correlation of activation with number of rtfMRI-
NF runs in the active relative to the control group, the statis-
tical blood oxygen level-dependent (BOLD) response is shown
for each group for each rtfMRI-NF run. (D) Statistical BOLD
response is shown for the 2 rIFG ROIs in the first and last
rtfMRI-NF run and in the transfer session in the active and
the control groups. (E) Three regions within the lPHG ROI (in
BA 30, BA 35, and BA 36) were significantly more linearly
activated across the 11 rtfMRI-NF runs in the control com-
pared with the active group. (F) The statistical BOLD
response for each group for each cluster within lPHG ROI
that was significantly more correlated with number of rtfMRI-
NF runs in the control relative to the active group was plot-
ted against the number of rtfMRI-NF runs for each group. (G)
Statistical BOLD response is shown within lPHG in the first
and last rtfMRI-NF run in the active and the control groups,
but there was no transfer effect. The functional data are
superimposed on a high-resolution anatomical template using
the MRIcron software [Rorden and Brett, 2000]. Peak Talair-
ach z-coordinates are indicated for slice distance (in mm)
from the intercommissural line. The right side of the image
corresponds to the right side of the brain. Note that “last”
rtfMRI-NF run refers to the 11th or earlier rtfMRI-NF run,
depending on whether the subject completed all 11rtfMRI-NF
runs. [Color figure can be viewed at wileyonlinelibrary.com]
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rtfMRI-NF Results
Repeated-measures between-group ANOVAs in ROIs
between brain activation of first and last rtfMRI-NF
run
The active relative to the control group showed signifi-
cantly increased activation in the last (11th or earlier) ver-
sus first rtfMRI-NF run within the rIFG-ROI (P < 0.05 for
voxel-, P < 0.01 for cluster-level) (BA 45; peak Talairach
coordinates (x;y;z;);36;41;13; P < 0.005; 16 voxels) (Fig. 2A).
No group differences in activation were observed in the
lPHG-ROI.
Group differences in linear correlation between brain
activation and number of rtfMRI-NF runs in ROIs
Within the rIFG-ROI, brain activation in BA44 (peak
Talairach coordinates (x;y;z), 36;14;29; P < 0.005; 75 voxels)
and BA45 [peak Talairach coordinates (x;y;z;);43;33;16; P <
0.005; 47 voxels] were significantly linearly increased
across the 11 rtfMRI-NF runs in the active compared with
the control group (P < 0.05 for voxel-level, P < 0.05 for
cluster-level; Fig. 2B–D). Within the lPHG-ROI, activation
in BA36 [peak Talairach coordinates (x;y;z;);222;27;226; P
< 0.01; 27 voxels], BA35 [peak Talairach coordinates
(x;y;z;);222;27;213; P < 0.03; 18 voxels], and BA 30 [peak
Talairach coordinates (x;y;z;);214;237;210; P < 0.04; 7
voxels] was significantly linearly increased across the 11
rtfMRI-NF runs in the control compared with the active
group (P < 0.05 for voxel-level, P < 0.05 for cluster-level)
(Fig. 2E–G).
rtfMRI-NF Transfer Session
Twenty-four participants completed the transfer session
(NActive5 13, NControl5 11). Only the active but not the
control group showed a significant transfer effect in their
respective ROI compared with the other group. A cluster
in rIFG-ROI (BA45; peak Talairach coordinates (x;y;z;),
40;37;13; P < 0.02; 6 voxels), was increased in activation in
the active compared with the control group during the
transfer session relative to baseline (P < 0.05 for voxel-
level, P < 0.01 for cluster-level; Fig. 2A,D).
Correlations Between ROI Brain Activation and
Clinical Outcome Changes
BOLD response was extracted for each subject in regions
that differed between groups in the rtfMRI-NF data analy-
ses. Exploratory correlations were performed with pre-
post primary and secondary outcome measure changes. In
the active group only, BOLD changes in rIFG-ROI (BA45)
during the transfer session were significantly negatively
correlated with reduced CPRS-R ADHD index score
(r520.6, P 5 0.02) (Fig. 3A). Activation changes in rIFG-
ROI (BA45) in the last relative to the first rtfMRI-NF run
Figure 3.
Scatter plots showing Pearson’s correlations between improve-
ments in primary and secondary clinical outcome scores (post-
pre) and statistical BOLD changes in brain activation in rIFG-
ROI for the active group. (A) In the transfer runs, the BOLD
response (increases) was significantly negatively correlated with
(reduced) CPRS ADHD index score. (B) There was a trend for
a negative correlation between an (increased) BOLD signal in
the last (11th or earlier) relative to the first rtfMRI-NF run and
(reduced) ADHD-RS Total score and (C) with (reduced)
ADHD-RS Hyperactivity/Impulsivity scores.
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were trend-wise negatively correlated with reduced
ADHD-RS total score (r520.3, P 5 0.09) (Fig. 3B) and
with reduced ADHD-RS hyperactive/impulsive symptoms
(r520.4, P 5 0.07) (Fig. 3C).
fMRI Stop Task
Two participants in each group did not complete the
post-rtfMRI-NF Stop task. Repeated-measures whole-brain
analyses showed that the active relative to the control
group had significantly enhanced activation during the
post-relative to pre-rtfMRI-NF Stop task in precuneus/
inferior/superior parietal lobule [BA7/40; peak Talairach
coordinates (x;y;z); 0;252;50; P < 0.001; 126 voxels) (P <
0.05 at voxel-level, P < 0.01 at cluster-level). Given our
hypothesis of brain activation changes in the rIFG-ROI, a
more lenient exploratory cluster-level threshold of P <
0.03 was also applied, showing increased activation in a
rIFG-ROI cluster (BA45; peak Talairach coordinates (x;y;z),
36;37;20; P 5 0.03; 13 voxels) in the active relative to the
control group at post- relative to pre-rtfMRI-NF (Fig. 4).
Whole-Brain Analyses of Commonly and
Differentially Linearly Increased Activation in the
Two Groups
Across both groups, increased activation that correlated
with number of rtfMRI-NF runs were in left DLPFC,
Figure 4.
Brain regions that showed increased activation to successful
Stop relative to successful Go trials post-rtfMRI-NF training
compared with pre-rtfMRI-NF training in the active compared
with the control group. Shown is increased activation in precu-
neus/inferior and superior parietal lobe (IPL/SPL) (P < 0.05 at
voxel, and P < 0.05 at cluster-level) and increased activation in
the apriori hypothesized right inferior frontal gyrus (rIFG) at a
more lenient cluster-level threshold of P < 0.03. On the lower
panel, the statistical blood oxygen level-dependent (BOLD)
response pre- and post-rtfMRI-NF is plotted for the rIFG and
the precuneus/IPL/SPL for each group. The functional data are
superimposed on a high-resolution anatomical template using
the MRIcron software [Rorden and Brett, 2000]. Peak Talairach
z-coordinates are indicated for slice distance (in mm) from the
intercommissural line. The right side of the image corresponds
to the right side of the brain. [Color figure can be viewed at
wileyonlinelibrary.com]
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supplementary motor area (SMA), insula, striato-
thalamic, inferior parietal, posterior cingulate, and precu-
neus regions (P < 0.05 for voxel-level, P < 0.05 for clus-
ter-level) (Fig. 5A, Table IV). Some of these activation
changes correlated with clinical ADHD symptom changes
(SMA/pre/postcentral gyrus with ADHD-RS inattention:
r520.4, P < 0.03; PCC/precuneus with CPRS-ADHD
index, r520.3, P < 0.03; left DLPFC with CPRS-ADHD
index; r520.4, P < 0.02; left premotor cortex/IFG with
ADHD-RS inattention; r520.4, P < 0.02). Activation in
left IFG/insula was progressively decreased across
rtfMRI-NF runs in both groups, but did not correlate
with symptom changes.
Areas in a cognitive control network comprising bilat-
eral DLPFC and IFG-insular-striatal and cerebellar
regions were progressively more increased in activation
across the rtfMRI-NF runs in the active relative to the
control group, while predominantly posterior temporal,
parahippocampal and occipital regions were more
increased in activation in the control relative to the active
group (P < 0.05 for voxel-level, P < 0.05 for cluster-level)
(Fig. 5B, Table V). No correlations with clinical symptom
changes were significant.
DISCUSSION
This is the first proof-of-concept rtfMRI-NF study in
ADHD children. It is also one of the few rtfMRI-NF stud-
ies that used several sessions and tested for short and
longer-term clinical effects. The study shows that adoles-
cents with ADHD were able to progressively self-
upregulate their allocated ROIs (i.e., rIFG, lPHG) across 11
rtfMRI-NF runs without side effects. Both groups showed
significant clinical symptom improvements with medium
to large effect sizes (Cohen’s d of 0.6 active, 0.8 control
group), after relative to before the rtfMRI-NF, which per-
sisted at follow-up at an average of 11 months. The study
thus proves for the first time feasibility, short- and longer-
term efficacy, and safety of rtfMRI-NF in a pediatric clini-
cal population. Group effects, reflecting region-specific
effects on clinical symptoms were not demonstrated. Only
the active (rIFG) group, however, showed significant trans-
fer effects which correlated with CPRS-R ADHD symptom
improvements, brain changes in their target ROI in the last
relative to first rtfMRI-NF run, which correlated trend-
wise with ADHD-RS symptom improvements, increased
rIFG activation in the Stop task and trend-level commis-
sion error reductions in the CPT. Most interestingly, the
Figure 5.
Whole-brain analysis showing commonly and differentially linearly
increased activation in the two groups. (A) Regions that show
progressively increased (red)/decreased (blue) activation across
both groups with number of rtfMRI-NF runs (whole-brain corre-
lation between number of rtfMRI-NF runs and brain activation
across both groups; see Table IV). (B) Regions that were signifi-
cantly more increased in activation across rtfMRI-NF runs in the
active relative to the control group (red) and in the control
relative to the active group (blue) (group differences in whole-
brain correlation between brain activation and number of rtfMRI-
NF runs; see Table V). The functional data are superimposed on a
high-resolution anatomical template using the MRIcron software
[Rorden and Brett, 2000]. Peak Talairach z-coordinates are indi-
cated for slice distance (in mm) from the intercommissural line.
The right side of the image corresponds to the right side of the
brain. [Color figure can be viewed at wileyonlinelibrary.com]
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effect size of improvement for pre-FU comparison was
large for the active group (0.94), relative to a much smaller
effect size of 0.5 for the control group, suggesting poten-
tially larger persistent effects of the rtfMRI-NF of rIFG
over the control group and compared with pre-post
changes in the active group. These findings suggest stron-
ger clinical, brain, cognitive, and brain–behavior associa-
tion effects in the active group.
The medium effect size for the pre-post comparison in
the active (and control) groups is comparable to typical
parent-rated effect size of 0.6 for stimulant medication
based on recent meta-analyses [Punja et al., 2016; Storebo
et al., 2015], while the effect size for the pre-FU contrast
reached almost 1 in the active group but only half of the
effect size for the control group. The findings of larger
improvements for pre-FU rather than for pre-post in par-
ticular in the active group are in line with EEG-NF find-
ings showing larger longer-term persistent over immediate
effects of NF after 6 months and even after 2 years [Arns
and Kenemans, 2014]. These longer-term persistent effects
were stronger for hyperactivity/impulsiveness than inat-
tention symptoms in the previous studies and the current
study, perhaps due to self-regulation training being more
beneficial to impulsiveness and self-control deficits [Arns
and Kenemans, 2014]. The stronger pre-FU than pre-post
effects may reflect lasting effects of brain self-regulation
training on brain plasticity that may build up over time.
The concept of a finite training providing longer-term per-
sistent changes is particularly attractive given that one of
the key limitations of stimulant medication is that effects
only last for 24 hours after administration and even with
chronic administration longer-term beneficial clinical
effects beyond several years have not been demonstrated
[Cunill et al., 2016; Molina et al., 2009], possibly due to
evidence for brain dopaminergic adaptation to the medica-
tion [Fusar-Poli et al., 2012; Wang et al., 2013].
It has also been argued, however, that the short- and
longer-term benefits of NF are not exclusively due to
improving specific neural mechanisms but may be mediat-
ed or moderated by (potentially compensatory) cogniti-
ve–behavioral (feelings of self-efficacy, achievement
motivation or the development of effective mental strate-
gies) and social (social reinforcement) interacting mecha-
nisms [Gevensleben et al., 2014; Thibault et al., 2016].
The stronger effects on cognitive performance in the
active than in the control group are in line with recent
findings from a small rtfMRI-NF study in 13 adults with
ADHD which also found stronger performance effects in
the NF relative to the control group (who did not receive
NF) in a similar sustained attention task and in visual
working memory [Zilverstand et al., 2017]. In line with
our hypothesis, the trend for performance improvement in
the CPT for the active group in our study was in commis-
sion errors, which are thought to reflect impulsiveness and
inhibitory mistakes [Halperin et al., 1992], thought to be
mediated by rIFG [Rae et al., 2014; Rubia et al., 2003].
While these findings of improvements in short- and
longer-term clinical measures are promising, the study
was relatively underpowered to test clinical and neuropsy-
chological efficacy and findings will need to be replicated
in larger patient groups.
Furthermore, the clinical improvements pre-post treat-
ment in both rtfMRI-NF groups could potentially be due
to unspecific attention or self-regulation effects, indepen-
dent of the NF, such as focusing on a rocket for a substan-
tial amount of time with the added bonus of a contingent
TABLE IV. Brain areas that were progressively increased/decreased with increasing number of rtfMRI-NF runs
across both groups combined
Brain regions of activation Brodmann’s area (BA)
Peak Talairach
coordinates
(x;y;z)
Cluster size
(voxels)
Cluster
P-value
Increased activation
Right posterior insula/putamen/superior temporal/
inferior parietal lobule
BA 42/22/40 43;219;10 86 0.0013
Left posterior cingulate/occipital/thalamus BA 23/29/31/17/18/19 27;285;10 870 0.0013
Left premotor cortex/inferior frontal gyrus BA 6/44 254;27;33 50 0.0013
Left superior/middle frontal gyrus BA 9/46 27;48;30 64 0.0013
Left superior/middle frontal gyrus BA 8 218;37;43 66 0.0013
Right inferior parietal lobule BA 40 36;241;40 70 0.0013
Right pre/postcentral gyrus/inferior parietal lobule BA 6/4/1/2/3/40 58;27;23 102 0.0013
Right posterior cingulate/precuneus BA 24/31/7 14;230;46 587 0.0013
Left pre/postcentral gyrus BA 6/4/3/2/1 236;22;66 66 0.0013
Bilateral supplementary motor area/pre/postcentral
gyrus
BA 6/4/3/2/1 0;233;73 115 0.0013
Decreased activation
Left inferior frontal gyrus/insula BA 47/44/45 243;15;0 112 0.0018
Analysis was conducted at voxel-level P < 0.05, cluster-level P < 0.003. See also Figure 5A.
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visual aid to help focusing on the task, or having to sit still
for four MRI scan hours. A placebo effect, which has been
shown to be superior with cutting-edge technology
[Thibault et al., 2016], could also explain the lack of
region-specificity on symptom improvements. However,
this is unlikely for the active group, given that the clinical
improvements correlated with the trained brain activation
changes in their ROI. While the active control condition
controlled for region-specificity, which is rarely addressed
in rtfMRI-NF [Thibault et al., 2015, 2016] or EEG-NF [Holt-
mann et al., 2014] studies, the inclusion of a sham-rtfMRI-
NF condition would have enabled us to rule out potential
placebo effects (but not nonspecific learning effects [Bau-
meister et al., 2016]).
The improvement of rIFG activation in the active group
in the stop task concomitant with no brain activation
changes in the control group is also interesting, given that
rIFG activation enhancement has been shown to be the
most consistent effect of stimulant medication on ADHD
brain function [Rubia et al., 2014b], suggesting comparable
neurofunctional effects of stimulant medication and
rtfMRI-NF of rIFG.
Only the active, but not the control group, showed
increased activation in their target region in the transfer
run and in the last versus the first rtfMRI-NF run, sugges-
ting stronger brain effects. It is possible that self-regulation
of rIFG is easier than self-regulation of lPHG, maybe due
to the fact that rIFG is a self-control region [Rae et al.,
2014; Rubia et al., 2003] and rtfMRI-NF self-regulation per
se, independently of the target region, has been shown to
activate rIFG [Emmert et al., 2016]. In line with this, there
is evidence that higher-order association regions are easier
to self-regulate than lower-level primary function regions;
in the same subjects, the inferior parietal lobe and higher-
level visual areas were easier to self-regulate than lower-
level visual areas such as V1 [Harmelech et al., 2015]. If
the lPHG-NF training is more challenging than the rIFG-
NF training, demanding superior self-regulation skills,
then this could potentially also explain the comparable
clinical improvements of both groups, despite lPHG not
being a key deficit region for ADHD.
The common effects could also be due to implicitly
trained, common brain activation changes related to both
groups trying to self-control their brain, independent of
the region. A meta-analysis of 11 rtfMRI-NF studies using
9 different ROIs, showed that, besides the trained ROIs,
participants co-activated a cognitive control network of
bilateral fronto-insular, striato-thalamic and parieto-
temporal regions presumably mediating self-regulation per
se, independently of the self-regulated region [Emmert
et al., 2016]. These are key areas of ADHD underactivation
[Cortese et al., 2012; Hart et al., 2012, 2013; Norman et al.,
2016; Rubia, 2011, 2017; Rubia et al., 1999, 2005, 2014a] and
overlap with regions of increased inhibition-related activa-
tion after EEG- and EMG-NF in ADHD [Baumeister et al.,
2016], suggesting that fMRI-NF induced neural self-
TABLE V. Brain areas that were differentially progressively increased with increasing number of rtfMRI-NF runs in
each group compared with the other group
Brain regions of activation Brodmann’s area (BA)
Peak Talairach
coordinates
(x;y;z)
Cluster size
(voxels)
Cluster
P-value
(a) Active group
Bilateral pons/cerebellum 4;222;240 158 0.0001
Left inferior frontal gyrus/anterior insula/putamen BA 47/45 236;15;27 37 0.0027
Right superior temporal gyrus/inferior frontal gyrus/
insula/putamen
BA 22/21/47/45 47;24;0 96 0.0019
Bilateral lingual gyrus/inferior/middle occipital gyrus BA 17/18/19 222;296;217 174 0.0001
Right superior/middle/inferior frontal gyrus BA 10/45/46 33;96;23 112 0.0003
Left superior/middle/inferior frontal gyrus BA 10/45/46 222;56;7 111 0.0003
Right inferior/frontal gyrus/pre/postcentral gyrus BA 44/9/6 36;15;30 406 0.0001
(b) Control group
Right orbitofrontal/superior/middle/ inferior/temporal/
(para)hippocampal gyrus
BA 47/38/21/20/37/35/36 51;15;226 192 0.0001
Left orbitofrontal/superior/middle/inferior/temporal/
(para)hippocampal gyrus
BA 47/38/21/37/35/36 261;241;210 460 0.0001
Bilateral cerebellum/occipital/parahippocampal gyrus BA 18/19/30 214;252;27 81 0.0015
Left postcentral/superior temporal gyrus BA 43/42/22 261;230;13 70 0.0018
Bilateral cuneus BA 18 18; 2100;13 130 0.0005
Left superior/middle frontal gyrus BA 8/9 229;22;53 65 0.0020
Left pre/postcentral gyrus BA 6/4/3/1 243;219;46 62 0.0017
Right supplementary motor area/midcingulate cortex BA 6/24/32 4;211;50 166 0.0001
Analysis was conducted at voxel-level P < 0.05, cluster-level P < 0.003. See also Figure 5B. Note that no brain regions were differentially
progressively decreased in any group.
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regulation may benefit ADHD children, independently of
the target ROI. This would be in line with findings of com-
parable parent-rated clinical ADHD improvements with
different self-regulation methods including near-infrared
spectroscopy (NIRS)-NF, EMG-NF, or EEG-NF [Marx
et al., 2014]. Our whole-brain analysis across both groups
in fact showed progressively increased activation through-
out the 11 rtfMRI-NF runs in DLPFC-parietal self-control
regions, some of which were correlated with clinical
changes, suggesting that they could have triggered the
clinical improvements (Fig. 5A, Table IV). However,
group-dissociated linear activation increases were also
observed, with bilateral DLPFC and rIFG-striato-insular
cognitive control network activation increase in the active
group and posterior temporo-parahippocampal/occipital
activation increase in the control group (Fig. 5B, Table V).
It is thus possible that the active group benefitted from
trained rIFG-striato-insular activation increase, while the
control group benefitted from trained activation increase
in posterior visual-spatial attention regions, which are con-
nected to lPHG [Aminoff et al., 2013], and both of which
are relevant to ADHD [Hart et al., 2012, 2013; Norman
et al., 2016; Rubia, 2011, 2017; Rubia et al., 2014a]. Hence,
both common and group-specific underlying processes
could have accounted for their clinical improvements. The
activation of a bilateral DLPFC/IFG-insular-striato-cerebel-
lar cognitive control network, and not just of rIFG, in the
active group, extends prior evidence for network activa-
tion in ROI based rtfMRI-NF [Emmert et al., 2016; Thibault
et al., 2015] and may have been underlying the transfer
effects, the attentional performance and the inhibitory
fMRI activation improvements that were specific to the
rIFG group.
Given that the control group learned to self-regulate
posterior attention regions, it is possible that the control
group was “too active” and therefore improved in clinical
symptoms. Future studies including a non-active control
condition such as sham-NF condition will be necessary to
assess rtfMRI-NF effects of rIFG.
A limitation of this proof-of-concept study is the small
participant numbers, which have limited particularly the
clinical efficacy and the brain-behavior correlation analy-
ses. Also, not all participants completed all runs. However,
a bias is unlikely, given that incompletion was due to tech-
nical scanner difficulties rather than to dissatisfaction or
lack of NF-learning. Although we aimed to include both
medication-na€ıve and medicated patients, in practice, most
patients in this age group are no longer medication-na€ıve
and hence the majority of patients were medicated. Future
studies will need to test the efficacy of rtfMRI-NF in
medication-na€ıve patients, which may well be stronger in
more symptomatic patients. Another limitation is that the
study was single-blind as the same researchers conducted
the rtfMRI-NF and scored behavioral questionnaires. How-
ever, primary and secondary outcome measures were
obtained from parent-reported questionnaires and their
blindness was effective. Also, follow-up measures may
have been confounded by other uncontrolled factors than
changes in medication status, which did not differ
between groups.
Although rtfMRI-NF is expensive, it could potentially
achieve a high cost-benefit ratio over long-term pharmaco-
therapy for ADHD, which is costly, if it treats the underly-
ing cause rather than symptoms of ADHD, reduces or
eliminates medication treatment, and has longer-term effi-
cacy and no side effects [Klora et al., 2016]. If rtfMRI-NF
proves to be a successful treatment for ADHD, it could
also be transferred to the cheaper NIRS-NF which has
already been piloted in ADHD [Marx et al., 2014] or to
fMRI-inspired EEG-NF methods, which use concurrent
fMRI-EEG-NF to establish the EEG correlates of localized
fMRI BOLD activity for a better spatially informed EEG-
NF [Keynan et al., 2016; Meir-Hasson et al., 2016].
In conclusion, this first proof-of-concept study in adoles-
cents with ADHD suggests that rtfMRI-NF of rIFG is feasible,
safe, transferrable and has short-term and even longer-term
efficacy in reducing ADHD symptoms. Furthermore, it is
associated with better inhibitory rIFG activation and trend-
level improvements in attention performance. However, repli-
cation in larger samples and a comparison with a sham-NF
placebo control condition to rule out placebo effects will be
needed to establish clinical efficacy.
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